Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.
1
2
3
4
5
Genefill DX, the only dermal filler with Dextranomer biostimulator.
The Dextranomer microparticles found in Genefill DX’s gel, along with cross-linked hyaluronic acid of non-animal origin, helps achieving a defined look and improves skin texture by regenerating the dermal matrix.
- Biostimluation: enhanced collagen and elastin production
- Tissue regeneration
- Biocompatibility
- Balanced inflammation control
- Balanced rheological properties”
Genefill DX is a high-concentration hybrid filler for the face that can provide volume and definition for improved facial contouring. The key ingredient is Dextranomer, responsible for inducing collagen and elastin production as well as helping with tissue regeneration.
Genefill DX delivers consistent, high-impact outcomes across facial applications. Its advanced biphasic formulation is fully biocompatible, biodegradable, and high-viscosity, designed to effectively volumize and hydrate the skin while supporting long-term tissue regeneration.
Physicians and patients can expect visible improvements in contour, elasticity, and overall skin quality.
Review before-and-after cases that showcase the precision, lift, and longevity achievable with Genefill DX.
%20After%20(2).png)
%20Before%20(2).png)
%20After.png)
%20Before.png)
%20After%20(1).png)
%20Before%20(1).png)
IMPORTANT SAFETY INFORMATION:
Genefill DX® is indicated for volume replacement/tissue augmentation, cheek area, marionette lines, deep wrinkles, nasolabial folds, and contour defects in the facial area. The result that can be achieved is dependent on skin type and the changes requested.
Genefill DX® must not be used in patients who have a tendency to hypertrophic and keloid scarring, have an intolerance towards gram-positive bacteria, are prone to active inflammatory or infectious processes, are suffering from acute or chronic skin diseases, are undergoing anti-coagulant therapy, have a known allergy against hyaluronic acid, or are suffering from autoimmune diseases. No clinical data is available on the application of Genefill DX® during pregnancy or lactation or to adolescents under 18 years of age. Patients with multiple allergies should be excluded from treatment.
Genefill DX® is intended for intracutaneous injection only and may not be injected into blood vessels as this could result in an occlusion of the vessels and embolism. The use of Genefill DX® is only permitted by trained medical personnel.
Genefill DX® is supplied in a sterile ready-to-use syringe, it is intended only for single use, and it may not be mixed with other injection agents.
The most common side effects are temporary erythema, slight swelling, pain, itching, discolouration, and hardening. Typically, these disappear spontaneously within 2 to 5 days following the injection.
